Trials / Completed
CompletedNCT01967082
APPSPIRE App in Preventing Students From Smoking
APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 24 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.
Detailed description
PRIMARY OBJECTIVES: I. Develop a prototype of the APPSPIRE (phone application \[app\] of a smoking prevention interactive experience). II. At post assessment, students enrolled in the study will qualitatively provide information about the usability and usefulness for the prevention and cessation sites. III. Investigate frequency of use of and exposure to APPSPIRE modules via an objective measure of general use. IV. Investigate how feasible the program will be. V. Obtain a maintained use of APPSPIRE with high completeness and extent of completion. VI. Evaluate change in stage of change from baseline to about 1 and 4-month follow-ups among participants. OUTLINE: Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | APPSPIRE | Given APPSPIRE app |
| BEHAVIORAL | Focus Group | Attend focus group |
| OTHER | Survey Administration | Complete survey |
Timeline
- Start date
- 2013-10-16
- Primary completion
- 2020-01-08
- Completion
- 2020-01-08
- First posted
- 2013-10-22
- Last updated
- 2020-01-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01967082. Inclusion in this directory is not an endorsement.